2025-06-26
Share

- Oncology SpecialistAssociate Chief Physician
- Associate Chief Physician
- Specialty: Specialized in personalized comprehensive treatment for complex cancers including lung cancer, liver cancer, colon cancer, gastric cancer, esophageal cancer, ovarian cancer, and cervical cancer. Skilled in interventional minimally invasive therapy, c...
| Introduction
Possesses nearly 20 years of clinical oncology experience within China's top-tier Grade A tertiary hospitals. Highly experienced in precision treatment fields such as minimally invasive interventional therapy for benign and malignant tumors, chemotherapy, and combined targeted-immunotherapy. Long-term focus on complex cancers including lung cancer, liver cancer, colon cancer, gastric cancer, esophageal cancer, ovarian cancer, and cervical cancer. Advocates for the Multidisciplinary Team model, leveraging rich and personalized comprehensive diagnostic and therapeutic experience. Accurately formulates individualized treatment plans based on patient condition and molecular pathological characteristics, aiming to enhance efficacy while improving patient quality of life and treatment experience.
| Medical Experience:
Member, Hepatobiliary and Pancreatic Tumors Professional Committee, Guangzhou Anti-Cancer Association
Member, Tumor Immunotherapy Professional Committee, Guangdong Pharmaceutical Association
Member, Interventional Medicine Professional Committee, Guangzhou Medical Association
Member, Liver Cancer Professional Committee, Tumor Rehabilitation Branch, Chinese Geriatrics Society
Member, Thyroid Nodule and Tumor Prevention and Control Professional Committee, China Health Care Association
| Academic Achievements:
Published 5 papers in core medical journals and 1 SCI-indexed paper
Awarded 1 Third Prize for Military Medical Achievements
Participated in 1 provincial-level government-funded research project
| Research Area:
Integrated Minimally Invasive Therapy for Tumors
Multidisciplinary Team (MDT) Precision Personalized Diagnosis and Treatment Model
Application of Combined Targeted and Immunotherapy Strategies in Oncology